Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.70% is 33% above its 5-year average of 2.03%, around the middle of its 5-year range (1.13%–3.90%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.95% below its 12-month average of 3.00%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.70%.
DEBT TO ASSETS RATIO
2.70%
DEBT TO ASSETS RATIO AVG TTM
3.00%
DEBT TO ASSETS RATIO AVG 3Y
2.37%
DEBT TO ASSETS RATIO AVG 5Y
2.03%
DEBT TO ASSETS RATIO AVG 10Y
10.40%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.95%
CURRENT VS 3Y AVG
+14.07%
CURRENT VS 5Y AVG
+32.87%
CURRENT VS 10Y AVG
-74.06%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+2898.14%
vs the sector median at left
Veracyte, Inc.
Market Cap
$3.57B
Debt to Assets Ratio
2.70%
TTM Avg
3.00%
3Y Avg
2.37%
5Y Avg
2.03%
Market Cap
$3.56B
Debt to Assets Ratio
0.67%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.54B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.51B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.49B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.44B
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.39B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Veracyte, Inc. (VCYT) | $3.57B | 2.70% | 3.00% | 2.37% | 2.03% |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.56B | 0.67% | N/A | N/A | N/A |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.54B | 0.03% | N/A | N/A | N/A |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.51B | 0.00% | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.49B | 0.91% | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.49B | 0.02% | N/A | N/A | N/A |
| Pulse Biosciences, Inc. (PLSE)vs › | $3.44B | 0.06% | N/A | N/A | N/A |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.39B | 0.04% | N/A | N/A | N/A |
| CareDx, Inc (CDNA)vs › | $3.39B | 0.04% | N/A | N/A | N/A |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | 0.04% | N/A | N/A | N/A |
Debt/Assets
2.7%
Debt/Equity
0.03
Current Ratio
9.16
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.70% |
| 2026-03-31 | 2.74% |
| 2025-12-31 | 2.82% |
| 2025-09-30 | 2.96% |
| 2025-06-30 | 3.77% |
| 2025-03-31 | 3.84% |
| 2024-12-31 | 3.90% |
| 2024-09-30 | 1.54% |
| 2024-06-30 | 1.68% |
| 2024-03-31 | 1.17% |
| 2023-12-31 | 1.13% |
| 2023-09-30 | 1.22% |
| 2023-06-30 | 1.28% |
| 2023-03-31 | 1.19% |
| 2022-12-31 | 1.27% |
| 2022-09-30 | 1.48% |
| 2022-06-30 | 1.54% |
| 2022-03-31 | 1.57% |
| 2021-12-31 | 1.59% |
| 2021-09-30 | 1.58% |
| 2021-06-30 | 1.67% |
| 2021-03-31 | 1.73% |
| 2020-12-31 | 2.69% |
| 2020-09-30 | 2.78% |
| 2020-06-30 | 5.08% |
| 2020-03-31 | 4.99% |
| 2019-12-31 | 4.94% |
| 2019-09-30 | 5.36% |
| 2019-06-30 | 5.65% |
| 2019-03-31 | 21.79% |
| 2018-12-31 | 20.96% |
| 2018-09-30 | 21.22% |
| 2018-06-30 | 38.59% |
| 2018-03-31 | 35.47% |
| 2017-12-31 | 32.09% |
| 2017-09-30 | 30.34% |
| 2017-06-30 | 28.78% |
| 2017-03-31 | 27.51% |
| 2016-12-31 | 25.26% |
| 2016-09-30 | 35.74% |
| 2016-06-30 | 32.97% |
| 2016-03-31 | 29.02% |
| 2015-12-31 | 6.68% |
| 2015-09-30 | 6.19% |
| 2015-06-30 | 6.03% |
| 2015-03-31 | 8.99% |
| 2014-12-31 | 7.59% |
| 2014-09-30 | 6.97% |
| 2014-06-30 | 7.34% |
| 2014-03-31 | 6.81% |
| 2013-12-31 | 6.15% |
| 2013-09-30 | 20.63% |
| 2013-06-30 | 17.77% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
